1月27日 - ** 医疗设备制造商 Outset Medical OM.O 股价盘前上涨 8%，至 5.30 美元
** 该公司称 (link)，美国 FDA 批准了其下一代透析系统 Tablo，该系统增加了可靠性功能
** 补充说，Tablo 的升级版网络安全符合 FDA 的最新标准
** Tablo 用于血液透析--一种在肾功能衰竭时过滤血液中废物的治疗方法
** 公司表示，硬件和软件更新的目的是减少医院的维护需求并提高耐用性
** 新系统将于 2026 年第二季度开始发货；现有用户可以升级
** 2025 年股价下跌约 78%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.